CPT 0369T: Duodenal Mucosal Resurfacing, Endoscopic
CPT code 0369T defines endoscopic duodenal mucosal resurfacing, an interventional endoscopic technique that ablates and remodels duodenal mucosa. The procedure is emerging in gastroenterology as a potential treatment for select duodenal and metabolic conditions. Nationally, adoption of this procedure affects endoscopy service utilization, facility preparedness, and payer coverage decisions for novel endoscopic therapies.
Key payers covered in this analysis include Aetna, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines which payers have explicit coverage language, common clinical indications associated with the procedure, and how this code relates to standard diagnostic upper endoscopy services. Readers will find benchmarks for billing and utilization patterns, policy and coverage considerations relevant to endoscopic therapeutic codes, and clinical context linking duodenal mucosal resurfacing to gastrointestinal disease indications.
This summary provides a concise resource for billing managers, gastroenterology groups, and compliance staff to understand the role of CPT code 0369T in clinical practice and payer policy. Data not available in the input is noted where applicable in detailed sections.
Customize your policy alerts
Sign up for cpt 0369T policy alerts
Get alerted when payer policies referencing 0369T are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 0369T describes duodenal mucosal resurfacing, endoscopic, a therapeutic endoscopic procedure that ablates and remodels the duodenal mucosa. The service type is an endoscopic therapeutic procedure typically performed in an endoscopy suite or ambulatory surgical center and may be delivered with monitored anesthesia care or sedation as part of routine endoscopic services.
National Reimbursement Benchmarks
National commercial pricing for CPT 0369T centers around an average commercial (BUCA) rate of $40.7, with BUCA’s interquartile spread running from $35.6 (P25) to $44.8 (P75). Cigna’s distribution aligns closely with the BUCA profile: mean $40.7, median $44.1, and the same P25/P75 bounds of $35.6 and $44.8, indicating a similar central tendency and upper-tail clustering near $44.8.
Comparing dispersion across the listed payers, both BUCA and Cigna exhibit an interquartile range of $9.2 (P75 $44.8 minus P25 $35.6), so neither payer is materially tighter or wider than the other on the middle 50% of rates. Cigna additionally displays an observed minimum of $35.6 and a maximum of $44.8, reinforcing that its overall spread mirrors the BUCA commercial average.